Company / Shareholders' Equity
Xencor Inc Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$635.6M
FY2025
5-year range
$593.2M / $727.5M
FY2021-FY2025
Trend
-6.2%
vs FY2024
Sector context
#74 of 213
Health Care
What the data says
At $636M, Xencor Inc's shareholders' equity ranks #74 of 213 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from $316M in FY2019 to $727M in FY2022.
Based on SEC 10-K filings.
$636M in FY2025 with a 5-year CAGR of +2.1%.
Declined from $662M to $636M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -4.4%
- 5-Year CAGR
- +2.1%
- 10-Year CAGR
- -
Sector benchmark
#74 of 213 in Health CareTop 35% of 213This company $635.6M Sector average $2.5B
▼
-75.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.1%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 6.2% year-over-year.
- Ranks #74 out of 213 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.27 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $635.6M | -6.2% |
| FY2024 | $677.6M | +2.4% |
| FY2023 | $661.8M | -9.0% |
| FY2022 | $727.5M | +22.6% |
| FY2021 | $593.2M | +3.6% |
| FY2020 | $572.4M | +80.9% |
| FY2019 | $316.5M | -6.4% |
| FY2018 | $337.9M | +6.8% |
| FY2017 | $316.5M | -6.4% |
| FY2016 | $337.9M | +108.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026